Is BMI a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Badger Meter (BMI) rests on Cellular AMI installed base: Badger Meter frames cellular AMI as the strategic gateway to digital-water adoption, driving meter and radio upgrades across utilities. The bear case rests on near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings. Analysts covering it publish targets from $112.00 to $170.00 against a $132.45 price, so even the professionals disagree by 37% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Badger Meter designs and sells water meters, flow-measurement instruments, and the radio and software layer (ORION and GALAXY radios, BEACON and OneNetwork software, and the broader BlueEdge portfolio) that turns municipal water systems into connected networks. Its core customers are North American water utilities upgrading from manual reads to automated meter reading (AMR) and advanced metering infrastructure (AMI), where cellular AMI acts as the gateway to leak detection, usage analytics, and recurring, high-margin SaaS revenue that compounds on top of the hardware installed base. The investment picture is one of quality over speed: BMI has raised its dividend for over 30 consecutive years, runs strong margins, and carries a large, multi-year pipeline of awarded AMI connections, but it also trades at a premium earnings multiple that leaves little room for disappointment. Q1 2026 showed the sensitivity of that setup, with sales and earnings falling year over year on slower short-cycle orders and utility-project timing, even as management pointed to a second-half recovery and continued expansion of software and "beyond the meter" offerings.
The bull case: what would have to be true for $170.00
The most optimistic published target on BMI is $170.00, +28.4% from the $132.45 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Cellular AMI installed base
Badger Meter frames cellular AMI as the strategic gateway to digital-water adoption, driving meter and radio upgrades across utilities. A larger installed base of connected endpoints creates a longer runway of replacement, expansion, and attach revenue. Management has cited a pipeline of roughly 2.6 to 3.6 million awarded AMI connections still to deploy.
2. Recurring software and SaaS attach
Hardware-enabled software such as BEACON and OneNetwork converts one-time meter sales into recurring, high-margin subscription revenue. As more of the installed base attaches software for leak detection and analytics, the mix shifts toward annuity-like revenue. This is the primary lever behind the company's structural margin-expansion thesis.
3. Beyond-the-meter and M&A
The BlueEdge strategy pushes Badger Meter beyond metering into broader water-quality and network monitoring across the water cycle. The pending roughly $100 million UDlive acquisition (announced April 2026, with an EBITDA-based earn-out) is an example of tucking in adjacent capabilities. A robust balance sheet supports opportunistic deals alongside organic growth.
4. Long-cycle utility demand and dividend record
Water-infrastructure modernization, driven by aging systems, water scarcity, and non-revenue-water losses, is a multi-decade secular demand backdrop. Badger Meter has increased its dividend for more than three decades (raised about 18% to roughly $1.60 per share in 2025). That consistency supports the case for owning it as a durable compounder rather than a trade.
The bear case: what would have to be true for $112.00
The most pessimistic published target is $112.00, -15.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Badger Meter is worth if the risks below bite instead of the drivers above.
Near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings. The stock carries a premium valuation (a P/E in the low-30s), so any growth disappointment can drive sharp multiple compression. Competition is intense from larger and well-capitalized rivals including Xylem (Sensus), Roper (Neptune), Mueller, and Itron, which can pressure pricing and share. Supply-chain costs, tariffs, and component availability can squeeze gross margins, and integration risk accompanies acquisitions like UDlive. Utility budgets and municipal funding cycles add cyclicality to an otherwise steady end market.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding BMI already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on BMI
9 analysts cover BMI, with an average target of $155.44 (+17.4% against $132.45) and a split of 7 buy, 5 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the BMI forecast and price target page.
How is BMI valued? (as of JULY 2026)
Snapshot for BMI as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$900M
- Q1 2026 net sales: ~$202M (down from ~$222M)
- Q1 2026 EPS: ~$0.93
- Market cap: ~$4.5B
- P/E (trailing): ~32x
- Dividend: ~$1.60/share (30+ years of growth)
Badger Meter is a profitable, mid-cap water-technology company with roughly $900 million in trailing revenue and mid-teens net margins. The premium P/E (about 32x) reflects the market pricing in durable software-driven growth and a long dividend record. Q1 2026 revenue fell about 9% year over year on softer project timing and short-cycle orders, and management guided to a second-half improvement excluding the UDlive deal.
How do you decide if BMI is a buy?
Rather than asking whether BMI is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold BMI indirectly through an index or sector ETF before adding more.
What would change your mind on BMI
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Cellular AMI installed base stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the BMI stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BMI against your real portfolio and see your actual exposure before deciding.
Investing in Badger Meter with AI
Connect the broker you already use and ask Walnut's AI how BMI fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is BMI a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Cellular AMI installed base, with revenue (ttm) at ~$900M. The bear case rests on near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings. Analysts covering it are spread from $112.00 to $170.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell BMI?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $112.00, -15.4% from the $132.45 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for BMI?
+
Cellular AMI installed base. Badger Meter frames cellular AMI as the strategic gateway to digital-water adoption, driving meter and radio upgrades across utilities. The most optimistic analyst target on BMI is $170.00, +28.4% from the $132.45 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for BMI?
+
Near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings. The stock carries a premium valuation (a P/E in the low-30s), so any growth disappointment can drive sharp multiple compression. Competition is intense from larger and well-capitalized rivals including Xylem (Sensus), Roper (Neptune), Mueller, and Itron, which can pressure pricing and share. Supply-chain costs, tariffs, and component availability can squeeze gross margins, and integration risk accompanies acquisitions like UDlive. Utility budgets and municipal funding cycles add cyclicality to an otherwise steady end market. The most pessimistic published target is $112.00, -15.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Badger Meter do?
+
Badger Meter designs and sells water meters, flow-measurement instruments, and the radio and software layer (ORION and GALAXY radios, BEACON and OneNetwork software, and the broade
What would have to change for BMI to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Cellular AMI installed base) stalling in the reported numbers rather than in the narrative, the risk above (near-term results are exposed to the timing of large utility AMI projects and to weaker short-cycle order rates, both of which pressured Q1 2026 revenue and earnings) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Badger Meter do?
+
It makes water meters, flow-measurement instruments, and the radios and software (ORION, GALAXY, BEACON, and the BlueEdge portfolio) that let water utilities read meters remotely, detect leaks, and analyze usage. Utilities are its core customers.
Is BMI a growth stock or a dividend stock?
+
It is often viewed as both: a steady grower tied to the multi-decade digital-water transition, and a dividend compounder with over 30 consecutive years of annual increases. The valuation reflects quality more than explosive near-term growth.
Why did BMI revenue fall in Q1 2026?
+
Net sales dropped to about $202 million from roughly $222 million a year earlier, which the company attributed to slower short-cycle orders and the timing of large utility AMI projects. Management pointed to a second-half recovery driven by its awarded-project pipeline.
Walnut is informational, not investment advice, and gives no verdict on BMI. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.